Suppr超能文献

Nimbus-匹兹堡大学轴流左心室辅助系统的研发进展

Progress on development of the Nimbus-University of Pittsburgh axial flow left ventricular assist system.

作者信息

Thomas D C, Butler K C, Taylor L P, Le Blanc P, Rintoul T C, Petersen T V, Griffith B P, Kormos R L, Borovetz H S, Litwak P, Kameneva M V, Choi S, Burgreen G W, Wu Z, Antaki J F

机构信息

Nimbus Inc., Rancho Cordova, California 95670, USA.

出版信息

ASAIO J. 1998 Sep-Oct;44(5):M521-4. doi: 10.1097/00002480-199809000-00040.

Abstract

Nimbus Inc. (Rancho Cordova, CA) and the University of Pittsburgh have completed the second year of development of a totally implanted axial flow blood pump under the National Institutes of Health Innovative Ventricular Assist System Program. The focus this year has been on completing pump hydraulic development and addressing the development of the other key system components. Having demonstrated satisfactory pump hydraulic and biocompatibility performance, pump development has focused on design features that improve pump manufacturability. A controller featuring full redundancy has been designed and is in the breadboard test phase. Initial printed circuit layout of this circuit has shown it to be appropriately sized at 5 x 6 cm to be compatible with implantation. A completely implantable system requires the use of a transcutaneous energy transformer system (TETS) and a diagnostic telemetry system. The TETS power circuitry has been redesigned incorporating an improved, more reliable operating topography. A telemetry circuit is undergoing characterization testing. Closed loop speed control algorithms are being tested in vitro and in vivo with good success. Eleven in vivo tests were conducted with durations from 1 to 195 days. Endurance pumps have passed the 6 month interval with minimal bearing wear. All aspects of the program continue to function under formal quality assurance.

摘要

Nimbus公司(加利福尼亚州兰乔科尔多瓦)和匹兹堡大学在美国国立卫生研究院创新心室辅助系统项目下,已完成了全植入式轴流血液泵开发的第二年工作。今年的重点是完成泵的水力开发以及解决其他关键系统组件的开发问题。在展示了令人满意的泵水力和生物相容性性能后,泵的开发重点转向了提高泵可制造性的设计特性。已设计出具有完全冗余功能的控制器,目前正处于试验板测试阶段。该电路的初始印刷电路板布局显示其尺寸合适,为5×6厘米,与植入兼容。一个完全可植入系统需要使用经皮能量传输系统(TETS)和诊断遥测系统。TETS电源电路已重新设计,采用了改进的、更可靠的运行拓扑结构。一个遥测电路正在进行特性测试。闭环速度控制算法正在体外和体内进行测试,取得了良好的效果。进行了11次体内测试,持续时间从1天到195天不等。耐力泵已通过6个月的间隔测试,轴承磨损最小。该项目的所有方面在正式的质量保证下继续发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验